�Home Diagnostics, Inc. (NASDAQ:HDIX), a preeminent manufacturer and marketer of diabetes testing supplies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for the world's smallest blood glucose meter, TRUE2go�, and for TRUEresult�, the company's up-to-the-minute advanced performance, no-coding metre for at home testing.
Small enough to twist and attach to the top of a vial of test strips, TRUE2go offers patients the convenience of anywhere, on the go testing to help them better deal their diabetes. TRUEresult, the latest state of the art, high performance meter, offers patients advanced monitoring capabilities at an affordable monetary value. In clinical testing, both systems achieved a high gear degree of accuracy and repeatability, and were considered to be easy to use by people with diabetes.
Both new meters are compatible with the company's new TRUEtest platform of blood glucose test strips featuring the company's patent-pending, state of the art GoldSensor� laser accuracy and TRUEfill� beveled tip. These advanced features ensure highly accurate test results and first test success by allowing for greater sampling precision and consistency.
The new TRUE systems feature article no-coding technology that simplifies blood glucose testing by eliminating the need for users to code the meter with each new box of test strips. Both TRUE2go and TRUEresult deliver precise results in as fast as four-spot seconds victimization only 0.5 microliters of blood. This ripe no-coding engineering combined with a small sample size also makes it more than convenient and cost - effective for diabetics to test their blood glucose levels more often, allowing for greater control of their glucose levels.
"Over the past three years we made capital investments in surfeit of $15 million in order to bring the TRUE2go and TRUEresult to market and are pleased to accept FDA clearance for the new products," said J. Richard Damron, Jr., President and Chief Executive Officer of Home Diagnostics. "Our new product platform is designed to fit people's needs whether they ar testing at home or on-the-go, fashioning it easier for them to prove accurately and quickly."
TRUE2go and TRUEresult will be available in the fourth quarter of this year.
About Home Diagnostics, Inc.
Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ:HDIX) is a leading developer, manufacturer and seller of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of superiority blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better reminder and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go�, TRUEresult�, TRUEtrack�, Sidekick�, TRUEread� and Prestige Smart System� blood glucose monitoring systems. The products are available in more than than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand provider of origin glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens as intimately as national distributors such as AmerisourceBergen, Cardinal Health and McKesson. For more information delight visit hTTP://www.homediagnostics.com.
TRUE2go, TRUEresult, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige Smart System ar trademarks of Home Diagnostics, Inc. All other trademarks are place of their respective owners.
Home Diagnostics, Inc.
More info
